SUBSCRIBE
SUBSCRIBE

Novartis Corporation To Warn US Doctors On Gleevec Heart Risks

October 3, 2006 | 
1 min read
ZURICH, Oct 3 (Reuters) - Swiss drugmaker Novartis will send a letter to U.S. doctors in the next few days to warn that there is a risk that its cancer drug Gleevec could cause heart damage, a spokesman said.

>>> Discuss This Story

Europe
MORE ON THIS TOPIC
German flags waving in the wind at famous Reichstag building, seat of the German Parliament (Deutscher Bundestag), on a sunny day with blue sky and clouds, central Berlin Mitte district, Germany.
Policy
Roche flags ‘final opportunity’ for Germany to reestablish as a reliable investment location
October 23, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Frankfurt Cathedral in Frankfurt am Main at sunset
Manufacturing
Sanofi breaks ground on insulin plant after securing German government support
October 19, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Cityscape of Madrid’s financial district at dusk, featuring modern skyscrapers illuminated against the fading evening sky. This area on the North of the city stands out as a symbol of contemporary architecture and economic dynamism in the Spanish capital, blending urban sophistication with a tranquil twilight ambiance.
cancer
Merck/Moderna, Summit/Akeso and ADCs to headline ESMO 2026
October 19, 2026
 · 
8 min read
 · 
Tristan Manalac
Flags of US, EU and China painted on cracked wall with people shadow
China
European biotech leaders split on US-China fight for deal dominance, survey finds
October 14, 2026
 · 
2 min read
 · 
Nick Paul Taylor